Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 4,000.00
+35.00 (0.88%)
Jul 21, 2026, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 92.22 billion as of July 21, 2026. Its market cap has decreased by -60.55% in one year.
Market Cap
92.22B
Enterprise Value
54.17B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,000.00
ChartMarket Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 92.22B, a decrease of -42.45%. That is a compound annual growth rate of -9.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 93.03B | -59.96% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 157.18B |
| Helixmith | 151.72B |
| NeoImmuneTech | 128.53B |
| Macrogen | 119.58B |
| Genexine | 104.15B |
| MedPacto | 89.63B |
| Amicogen | 80.18B |
| iNtRON Biotechnology | 76.51B |